NasdaqCM - Nasdaq Real Time Price USD

OptimizeRx Corporation (OPRX)

9.98
+0.07
+(0.71%)
As of 3:16:13 PM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Stephen L. Silvestro President & CEO 544.96k -- 1978
Mr. Edward Stelmakh C.M.A., M.B.A. CFO & COO 578.48k -- 1966
Mr. Andrew Jacob D'Silva Senior Vice President of Corporate Finance -- -- --
Ms. Marion K Odence-Ford Chief Legal Officer & Chief Human Resources Officer 428.12k -- 1965
Ms. Maira Alejandra Media Relations Manager -- -- --
Dr. Doug Besch Chief Product Officer & CTO -- -- 1982
Ms. Theresa Greco Chief Commercial Officer -- -- 1973
Ms. Heather Favazza Controller -- -- --
Ms. Sheryl Kearney Human Resources Manager -- -- --

OptimizeRx Corporation

260 Charles Street
Suite 302
Waltham, MA 02453
United States
248-651-6568 https://www.optimizerx.com
Sector: 
Healthcare
Full Time Employees: 
128

Description

OptimizeRx Corporation, a digital health technology company, engages in the provision of tech-enabled marketing solutions for life sciences organizations, healthcare providers, and patients. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. It also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is based in Waltham, Massachusetts.

Corporate Governance

OptimizeRx Corporation’s ISS Governance QualityScore as of May 1, 2025 is 8. The pillar scores are Audit: 10; Board: 2; Shareholder Rights: 4; Compensation: 10.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 12, 2025 at 8:00 PM UTC

OptimizeRx Corporation Earnings Date

Recent Events

April 30, 2025 at 12:00 AM UTC

ARS: Annual Report to Shareholders

April 18, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 3, 2025 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

March 28, 2025 at 12:00 AM UTC

S-3: Offering Registrations

March 20, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

March 12, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 10, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 10, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 23, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 14, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

Related Tickers